Cargando…
Circulating proteomic signature for detection of biomarkers in bladder cancer patients
The identification of clinically-relevant early diagnostic and prognostic protein biomarkers is essential to maximize therapeutic efficacy and prevent cancer progression. The aim of the current study is to determine whether aberrant plasma protein profile can be applied as a surrogate tool for early...
Autores principales: | Nedjadi, Taoufik, Benabdelkamal, Hicham, Albarakati, Nada, Masood, Afshan, Al-Sayyad, Ahmed, Alfadda, Assim A., Alanazi, Ibrahim O., Al-Ammari, Adel, Al-Maghrabi, Jaudah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335182/ https://www.ncbi.nlm.nih.gov/pubmed/32620920 http://dx.doi.org/10.1038/s41598-020-67929-z |
Ejemplares similares
-
Proteomic Profiling of Plasma-Derived Biomarkers in Patients with Bladder Cancer: A Step towards Clinical Translation
por: Nedjadi, Taoufik, et al.
Publicado: (2021) -
Sonic Hedgehog Expression is Associated with Lymph Node Invasion in Urothelial Bladder Cancer
por: Nedjadi, Taoufik, et al.
Publicado: (2018) -
The prognostic impact of GSTM1/GSTP1 genetic variants in bladder Cancer
por: Albarakati, Nada, et al.
Publicado: (2019) -
Prognostic value of HER2 status in bladder transitional cell carcinoma revealed by both IHC and BDISH techniques
por: Nedjadi, Taoufik, et al.
Publicado: (2016) -
Obesity Proteomics: An Update on the Strategies and Tools Employed in the Study of Human Obesity
por: Masood, Afshan, et al.
Publicado: (2018)